Efficacy and safety of immune checkpoint inhibitors in post-TKI NSCLC patients harboring EGFR mutations
Si Sun, Chang Liu, Chunyan Duan, Songxia Yu, Qiao Zhang, Nana Xu, Bo Yu, Xianghua Wu, Jialei Wang, Xingjiang Hu, Hui Yu
Topics & Concepts
MedicineInternal medicineOncologyLung cancerHematologyProgression-free survivalChemotherapyClinical endpointEpidermal growth factor receptorClinical trialCancerLung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and Treatment